2019 Novel Coronavirus (COVID-19) continues its rapid proliferation across the globe with complex and widening implications. While much remains unknown, King & Spalding is mobilized to assist our clients, helping them address early stage responses across their operations, while factoring in the long-term commercial and legal impact, including a return to the office, recovery, and government enforcement.
King & Spalding’s Crisis Practice, which includes lawyers from our Special Matters and Government Investigations, Employment, Corporate Governance, Insurance Coverage and Recovery, Litigation, International Arbitration, Government Advocacy and Public Policy, Leveraged Finance, Restructuring, Antitrust, Trade, Real Estate and Data, Privacy and Security teams, brings experience and judgment to help the c-suite, legal team and the Board address mounting business and legal issues. Our clients benefit from the perspective of our leading Healthcare and Life Sciences team, which is in regular contact with the CDC and other regulatory bodies that are coordinating the U.S. government’s response. We are also able to leverage relationships with premier global duty of care and crisis communications advisors to help our clients stay in front of today’s unprecedented and rapidly unfolding developments.
As our clients navigate a return to work in the context of an ever-changing “new normal,” we have thought through the judgment calls clients need to make at this critical juncture.READ MORE
A survey that actively tracks the status of federal and state price gouging provisions and provides an overview of the applicable pricing limitations currently in effectRead More
Survey of State and Municipal Shelter-in-Place / Stay-at-Home OrdersView Orders
In the wake of the coronavirus pandemic, regulatory agencies are issuing press releases and regulatory guidance affecting financial services firms. Read more about the summaries and links to guidance issued by the US, UK, and European financial regulators concerning COVID-19.Read More
A survey of residential and commercial restrictions on eviction or other contractual remedies as well as foreclosuresRead More
A live tracker of COVID-19-related SEC filings and disclosure issuesREAD MORE
A high-level summary of state proposals to limit liability for healthcare providers and consumer-facing businessesREAD MORE
At this critical juncture of distribution, our COVID-19 Vaccine Rollout Task Force is drawing on our industry knowledge and client relationships to serve as a guiding light and partner to our clients.Read More
September 29, 2021
Employment Tribunal Rulings On Return To Work Refusals – What Can We Learn?
October 13, 2021
Steve Cave discusses Texas Governor Greg Abbott's ban on COVID-19 vaccine mandates and the likelihood it will be superseded by the Biden administration’s plan to require shots for workers
September 27, 2021
Mark Polston examines the call to the government from medical groups and health lawyers to give hospitals more time and clarity on reporting how they spent governmental pandemic assistance money
September 27, 2021
Dan Hettich and Ahsin Azim comment on HRSA’s COVID-19 claims reimbursement to healthcare providers and facilities for testing, treatment, and vaccine administration for the uninsured